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Diffuse subtypes of cutaneous lymphoid hyperplasia (CLH; 
= 18) and primary malignant follicular center cell lym-
J1 homa of the skin (FCCL, n = 11) were diagnosed by COI1 -~cntional histology, immunophenotyping on paraffin sec-
tions, and gene rearran~ement a~alysis. We. then counted on 
scmithin, Azur A - sta1l1ed. sectlOns of res1l1- re-e~bedd.ed 
biopsy specimens the relauve numbers of apoptotlC bodies 
Jllong all lymphoid cells (apoptotic index [AI]). The diag-~ostic value of AI was compared to that of mitotic indices 
(MI) and percentages of various cell types in the cutaneous 
·IJiltrate. Features of cellular infiltrates distinguishing to two ~roups of lesions, in the order of decreasing significance, 
were percent large ly~pho.id cells, percent medium-sized 
lymphoid cells (both higher 111 FCCL); percent small lymph-
oid cells, percent epithelioid/giant ceJls, and percent histio-
T he differential diagnosis of benign and malignantcuta-neous lymphoid cell infiltrates is one of the most dif-ficult tasks in dermatopathology [1]. Immunohisto-chemistry has greatly helped to distinguish cutaneous lymphoid hyperplasia (CLH), also called pseudolym-
ho ma or lymphadenosis benigna cutis, from malignant lympho-~a5 other than mycosis fungoides [2,3]; however, markers are not 
infallib le [4]. Further, there ~re pit~alls in the application of molecu-
lar biologic methods, e.g., 111 the lI1terpretauon of Sou.thern blots 
[5]. Thus, the e.valuatioll of doubtful cases wIth lymphOId cellllllil -
crates in the skl11 must sull be based 01: a constell~tlon of features, 
including morphology, and not on a sll1gle wtenon [6). 
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Abbrevia tions: 
AI: apoptotic index (indices) 
CLH: cutaneous lymphoid hyperplasia, diffuse subtype 
FCCL: malignant follicular center cell lymphoma, diffuse subtype 
MI: mitotic index (indices) 
P AS: periOdic acid-Schiff 
peR: polymerase chain reaction 
SIg: surface immunoglobulins 
cytes/macrophages (all three higher in CLH). However, of 
all parameters tested, AI had the greatest discriminant value 
(median in FCCL 1.11%, in CLH 0.14%; P = 8 X 10-6 ). 
Two cases, diagnosed as CLH with all morphologic and im-
munologic methods used, showed B -cell monoclonality at 
the D~A level. Linear discriminant analysis determined the 
followmg order of distinctive power of variables: 1) AI; 
2) MI; 3) per~ent small lymphoid cells; 4) percent medium-
SIZed lymphOId cells; 5) percent large lymphoid cells; 6) per-
cent epithelioid/giant cells; and 7) percent histiocytes/mac-
rophages. The present study thus establishes AI as an 
important parameter in the differentiation of diffuse CLH 
from diffuse cutaneous FCCL. ] Irwest Dermatol 100:699-
704, 1993 
A distinct group of primary cutaneous malignant B-celilympho-
mas of follicular center cell origin (FCCL) has been recognized 
recently. It exhibits preferential involvement of the head and trunk, 
an indolent clinical course, and a favorable prognosis after adequate 
treatment [7 -9). Therefore, special efforts should be made to find 
an optimal set of parameters on which the diagnosis may be based. It 
has been shown in our laboratory that in diffuse nodal , i.e. not 
cutaneous, FCCL the malignancy grade correlated significantly not 
only with proliferative activity but also with cell death rate, as 
indicated by apoptotic indices [10]. It is difficult, if not impossible, 
to apP.ly current c ~ assifications of non-Hodgkin'S lymphomas 
(Workll1g Formulation [11). updated Kiel classification (12)) and 
their prognostic value to primary lymphoid cell neoplasias in the 
skin [8]. Therefore, we wanted to test the value of the apoptotic 
index in the differentiation of diffuse cutaneous FCCL and CLH. 
To evaluate the relative importance of this feature, other parame-
ters, such as mitotic indices (MI) and cellular composition of infil-
trates, were also assessed. 
MATERIALS AND METHODS 
Conventional Histology and Selection of Cases Skin biopsy 
specimens from patients with CLH (n = 18) or FCCL (n = 11), 
taken at various hours of the day, were collected from the fil es of the 
Institute of Pathologic Anatomy and Histology, University of 
Siena, Italy (Table I). Tissues were fixed in a buffered 4% aqueous 
formaldehyde solution, pH 7.4, and processed to obtain 4-f.lm-
thick paraffin sections. Stains used for qualitative histologiC evalua-
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Table I. Clinicopathologic, Immunohistochemical, and Immunogenetic Data 
IgH Chain Gene 
Case Age (years) Sex Site Histologic Diagnosis' Immunophenotypeb Rearrangement' Treatment" Status' 
1 56 F Forehead CHL,d B = T S A 
2 50 M Scalp CHL,d B :5 T S A 
3 67 M Arm CHL,d B < T S A 
4 26 F Cheek CHL,d B = T S A 
5 28 F Cheek CHL,d B "= T S A 
6 26 M Nose CHL,d B < T + S A 
7 47 F Scalp CHL,d B ?: T S A 
8 72 M Chest CHL,d B > T + S A 
9 45 F Scalp CHL,d B > T S A 
10 62 F Arm CHL,d B "= T S A 
11 5 F Ear CHL,d B < T S A 
12 30 M Scalp CHL,d B < T S A 
13 28 F Arm CHL,d B > T S A 
14 86 M Nose CHL,d(f) B > T S A 
15 70 M Scalp CHL,d B ?: T NI S A 
16 44 F , Shoulder CHL,d B ?: T S A 
17 49 F Chest CHL,d(f) B < T NI S A 
18 5 F Face CHL,d B > T NI S A 
19 58 F Back FCCL,G,d B > T + S,R A 
20 83 F Scalp FCCL,G,d B :» T + S A 
21 65 F Chest FCCL,F,d B :» T + S,R A 
22 58 M Back FCCL,F,d B :» T + S,R A 
23 55 M Shoulder FCCL,F,d B :» T NI S,R A 
24 49 M Back FCCL,F,d B :» T + S,R A 
25 70 M Scalp FCCL,F,d B :» T NI S D 
26 49 M Back FCCL,E,d B :» T + S,R A 
27 80 F Leg FCCL,F,d B :» T + S D 
28 51 F Back FCCL,G,d B :» T NI S,R D 
29 64 M Scalp FCCL,E,d B :» T NI S A 
• CHl, cutaneous lymphoid hyperplasia; FCCl, malignant follicular center cell lymphoma; d, diffuse; (f), very few follicles: E, F, G, analogues of Working Formulation code: 
E, small cleaved cell; F, mixed, small and large cell; G, large cell. 
• Percentage of B (L26+, 4KB5+) and T (UCHLI+, MT1+) lymphoid cells: "", about equal; 2:, slightly; >, moderately; » , markedly higher. All FCCl had lNl+ cells 
(range, 10-60%). 
, NI, not interpretable because of insufficient amounts of extracted DNA. 
J 5, surgery; R, radiation therapy, i.e., x-rays and PUVA (photochemotherapy ultraviolet A). 
, A, alive; D, dead. Follow-up period of 3 years. 
tion included hemalum and eosin, Giemsa, periodic acid-Schiff 
reagent (Pas), M allory's trichrome, and Gomori's silver impregna-
tion . Case selection criteria were as follows : no treatment before 
diagnosis; diffuse pattern of lymphoid cell infiltrates in the skin; and 
lack of evidence for secondary disease after extensive staging proce-
dures [8] . Diagnoses were established after independent evaluation 
by, and consensus among, four experienced pathologists, on the 
bas is of recently published histologic and immunophenotipic cri-
teria [4,9]' i.e. , without paying any attention to the magnitude of 
cell death. 
Immunophenotypic Analysis Immunohistochemistry on par-
affin sections comprised the application of a panel of mo noclonal 
antibodies recognizing formalin-resistant epitopes [13]. In particu-
lar, we used (major specificities in parentheses) from Dakopatts 
(Copenhage n, Denmark) L26 (anti-CD20, B lymphocytes), 4KB5 
(anti-CD45RA, B lymphocytes), and UCHLl (anti-C D45RO, T 
lymphocytes, myeloid cells); from Biotest (Dreieich, FRG) LN1 
(anti-C D75, follicular center cell s); and from C lonab (Francfortj 
M , FRG) MT1 (anti-CD43, T lymphocytes, myeloid cells). Nor-
mal human tonsils served as positive controls. N egative controls 
consisted in replacing primary antibodies by l\onnal mouse serum. 
Polymerase Chain Reaction (PCR) for Demonstration of 
Clonal Immunoglobulin Heavy-Chain Gene Rearrange-
ments Because monotypic expression of surface immunoglobulin 
(SIg) li ght chains usuall y cannot be assessed in paraffin sections of 
formalin-fixed ti ssue and is often weak or undetectable even in 
frozen sections ofFCCL [2], we applied a slight modification of the 
recently reported method for the demonstration of B-cellmonoclo-
nality in paraffin sections using the PCR [14]. T en-micrometer -
thick tissue sections were deparaffinized, washed in 100% ethanol, 
dried, and incubated for 3 h at 55 0 C in 200111 of di gestion buffer (50 
mM Tris-HCl, pH 8.5; 1 mM EDT A; 0.5% Tween 80) containing 
200 I1gjml of proteinase K (Boehringer, M annheim, FRG). Th~ 
resulting templ ate DNA solution was then boiled to inactivate the 
proteinase K. A semi-nested PCR was carried out in a Biostar T her-
mal Cycler, using the primers Fr3A, LJH, and VLJH (synthesized 
by M -Medical , Florence, Italy) to amplify the V -D-J region of th~ 
immunoglobulin (Ig) heavy chain gene. Fr3A is based on a consen-
sus sequence from 17 human V-segments; LJH and VLJH are based 
on a consensus from the six J regions. The reaction mix (50 ilL) 
contained 10 Jll of the DNA template solution; 0 .25 mM each of 
dATP, dGTP, dTTP, and dCTP; 0.0511g of each primer; 2.5 units 
of Taq polymerase (Promega, Madison , WI) ; and buffer (Promega) 
with 4 .5 mM M gCI2 • Each reaction mix was overlaid with a drop of 
mineral oil. A PCR cycle comprised annealing for 50 seconds at 
56 0 C, extension for 60 seconds at 72 0 C, and denaturation for 60 
seconds at 95 0 C. The semi-nested PCR consisted of a first round of 
40 cycles with the primers Fr3A and LJH , and a second round of30 
cycles with Fr3A and VLJH, using 10 111 of the 1 : 1000 diluted fi rst 
PCR product as template. A discrete band, about 100 -120 kilo base 
pairs long, in 2% agarose gel with electrophoresed PCR amplified 
material (5111), indicates monoclonality. Negative controls for re-
agent contamination, consisting of all PCR reagents except tem-
plate DNA, w ere applied each time a PCR assay was performed. 
DNA extracted from a nodal large cell FCCL was employed as 
positive control. 
Re-Embedding of Biopsy Specimens in Plastic and Test 
Point Analysis of Cellular Infiltrates Cytologic details [15) 
and apoptotic bodies [16] are better visualized in semithin secrion 
o f plastic-embedded material than in paraffin sections. Therefore, 
we re-embedded parts of the biopsy specimens from paraffin in 
Epon-Araldite resin (Monojet, Kildare, Ireland) . Sections , 2 pm 
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figure 1. Characteristic aspect of apoptotic bodies (arrows) in semithin 
sections of resin-embedded cutaneous diffuse malignant FCCL. Notice 
Ihe clumping and effaced chromatin pattern of nuclear remnants. a, tolUI-
dine blue; b, Azur A (bars, 10 jlm). 
hick, were stained with Azur A, to show the nuclear chromatin 
~ttern, to luidineblue, and other co l o ra nt~ (see above). In each case, 
atest point analys Is [17] was carn ed out, USing a 1 OO X 011 Immersion 
objective and a 10 X eyepiece. Counts were made blmdly by two 
pathologists on 15 ra ndoml y chosen fields (28,000 /1m2 per field, 
wtal number of cells per case about 2,500 - 3,000). Small, medium-
sized, and large lymphoid cells were registered based on their mor-
phology a nd staining characteristics (nuclear size, chromatin pat-
tern, nucleolar size, nuclear/cytoplas mic ratio). Plasma cells, 
neutrophils, eosinophils, histiocytes/ macrophages, epithelioid, 
giant cells, and mast cell s were also counted. 
Assesstnent of Mitotic and Apoptotic Indices Also for this 
analysis, the pathologists making the counts were blinded to 
whether they were looking at CLH or FCCL. In each case, the 
mean number of lymphoid cells per field was registered in 15 ran-
domly chosen fi elds (see above). Mitotic fi gures and apoptotic 
bodies were then counted in a greater number of fields and ex-
pressed as percentages of lymphoid cells per case, i. e., MI and AI, 
respectively. Care was taken to clearly define apoptotic bodies [10] . 
They contain , or consist of, single or- less frequently - grouped 
dense nuclear remnants exhibiting highly condensed (pyknotic) 
chromatin with an effaced, often homogeneous pattern at light 
microscopy (Fig 1) . More than one I.'yknotic fragment per " halo" 
were counted as one apoptotic body [1 6J. In the two cases ofCLH 
with abortive secondary follicles (Table 1) , "tingible body macro-
phages" within the respective centers were excluded from the 
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Table II. Significant Differences Between Diffuse Cutaneous 
Lymphoid Hyperplasia and Malignant Follicular Center Cell 
Lymphomas in the Cellular Composition of Infiltrates 
Percentage of Cells in Infiltrates' 
Cell Type CLH FCCL P Value 
Large Iymph- 4.0 (0 - 6.S) 14.7 (6.4 - S1.4) 1 X 10- 5 
oid cells 
Medium-sized 4.3 (0 - 12.0) 34.9 (6.0 -59.5) 2 X 10- 5 
lymphoid 
cells 
Small Iymph- 50.0 (32.S -72.0) 17.9 (0 .5-54.0) 1 X 10- ' 
oid cells 
Epithelioid 11.4 (0 -44.6) 0.0 (0 - 20.0) 1 X 10- 3 
and giants 
cells 
Histiocytes, lS.5 (1.4 -31.1) 13.0 (4.6-17.5) 1 X 10- 2 
macro-
phages 
• All intact infiltrate cells a t the exclusion of fibroblasts, blood vessel components 
and epithelial cells. Between CLH and FCCl there were no significant differences in 
the percentage of plasma cells, neutrophils, eosinophils, and mast cells. Values are 
medians, with ranges in parentheses. 
counts. This was done because the study is restricted to diffuse 
lymphoid cell infiltrates. 
Reproducibility of Counts Counts were repeated seven times 
by two independent observers in fiv e cases. The correlation coeffi-
cient was greater than 0.95 . 
Transmission Electron Microscopy In several cases, apoptotic 
bodies were also studied in transmission electron micrographs as 
described previously [10J . 
Statistical Methods Statistical analyses of counting results were 
carried out by use of the program SYSTAT 5 for MACINTOSH 
[18]. In the monovariate analysis, we calculated for each group 
(CLH, FCCL) and for each parameter the mean, the standard devia-
tion (SD) of the mean, skewness, and kurtosis. The signific,ll1ce of 
differences between groups, as regards a single parameter, was exam-
ined with the hel p of the Kruskal-W allis one-way analysis of var-
iance. We considered p values equal to, or smaller than, 0.05 as 
significant. Pearson's correlation matrix was employed to evaluate 
correlations between individual variables. A linear discriminant 
analys is [1 9] served to assess the relative power of individual parame-
ters to discriminate between CLH and FCCL. 
RESULTS 
Convent ional Histology and Immunophenotypic Analysis 
The morphologic evaluation of infiltrates was largely based on cyto-
logiC detads given I.n the Working Formulation [1 1 J and the up-
dated Kiel claSSIfication [1 2] as well as in more recent descriptions of 
CLH and cutaneous FCCL [4,6,8,9]. Diagnoses, supported by im-
munophenotyping, are listed in Table I. 
Polymerase Chain Reaction for Demonstration of Clonal 
Immunoglobulin Heavy-Chain Gene Rearrangements In 
several cases, the PCR assay gave no interpretable results because of 
insufficient amount of extracted D N A. However, all seven success-
fu lly tested FCCL showed B-ce ll monoclonali ty at the DNA level. 
C lonal Ig heavy-chain gene rearrangements were also found in two 
of the 15 CLH in which the PCR assay produced satisfactory band-
ing (Table I) . 
Test Point Analysis of the Cellular Composition of Cutane-
ous Infiltrates Monovariate analysis revealed marked differences 
between CLH and FCCL with regard to severa l components of 
cellular infiltrates (Table II) . In order of decreasing significance, 
these were the percentages of large and medium-sized lymphoid 
cells, which predominated in FCCL, and of small lymphoid cells, 
epithelioid and giant cel ls, and histiocytes/macrophages, that were 
702 MlRACCO ET AL 
Figure 2. Ultrastructural fea~res of an apoptotic body in the early phase 
of cell disintegration. The chromatin is clumped and fragmented, the 
cytoplasm condensed (bar, 1 Jim). 
higher in CLH. All other registered cells types showed no signifi-
cantly different percentages in the two groups of disorders. 
Mitotic and Apoptotic Indices The recognition of apoptotic 
bodies in semithin sections of resin-embedded tissue caused no diffi-
culties (see Fig 1). Samples examined by transmission electron mi-
croscopy (Fig 2) exhibited the ultrastructural characteristics of 
apoptosis [20] . The numbers of apoptotic bodies, expressed as per-
centage oflymphoid cells per case (AI), are shown separately for the 
two groups of disorders in Fig 3. The values for FCCL (median, 
1.11 %; range, 0.88 - 1.58%) were much higher (p = 8 X 10-6) 
than those for CLH (median, 0.14%; range, 0 - 0.41 %) and no over-
lap was observed. The proliferative activity in the infiltrates, indi-
cated by the percentage of mitotic figures per case (MI), similarly 
discriminated between FCCL (median, 1.00%; range, 0.47-
1.64%) and CLH (median, 0.09%; range, 0 - 0.50%); however, 
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Figure 4. Apoptotic indices per case plotted against mitotic indices (Ml, 
a) or the natural logarithm of percent large lymphoid cells (In [% LLC]), b) 
per case (symbols as in Fig 3). The clusters of points for CLH and FeCI.. 
respectively, are clearly separated from each other. Intra-group correla-
tion is Significant only for FCCLin b (y = 2.74x - 0.28; r = 0.79; P = 5 
10 - 3). 
there was a slight overlap between the two groups, and the signifi-
cance of difference was slightly less marked (p = 1 X 10- 5). 
Correlations Between Variables We did not accept as trot 
correlations between variables those that were "significant" only if 
both groups were taken together, but lost significance if either CLH 
of FCCL alone were considered. This is exemplified in Fig 4. T ht 
apparent "correlations" between AI and MI (Fig 4a) and between 
AI and the natural logarithm of percent large lymphoid cells 
(In[%LLC], Fig 4b) are mainly due to highly significant differences 
between groups (see Fig 3 and Table II), but not or much less to an 
intra-group correlation. In Fig 4, the latter was only significant for 
AI and In(%LLc) in FCCL (semilogarithmic plot, r = 0.79, P = 
5 X 10- 3) . Significant linear intra-group correlations of variables 
are listed in Table III. There were also indirect correlations, e.g. , in 
FCCL between AI and MI via the significant positive correlation 
between both these parameters and the percentage of large lymph. 
oid cells. The direct correlation in this group between Al and Ml, 
however, did not attain significance. 
Discriminant Analysis With regard to the distinction between 
histologically diagnosed CLH and FCCL, linear discriminant analy-
sis determined the following order of discriminant value of vari-
ables: 1) AI; 2) MI; 3) percent small lymphoid cells; 4) pereen! 
medium-sized lymphoid cells; 5) percent large lymphoid cells; 6} 
percent epithelioid/giant cells; and 7) percent histiocytes/macro-
phages. Thus, the relative number of apoptotic bodies distinguished 
better between diffuse CLH and FCCL than any other paramer~r 
tested . Data obtained with immunophenotyping and PCR were 0 
included into the linear discriminant analysis because they wert 
registered as semiquantitative values. But it would appear, from 
comparing Table I and Fig 3, that the discriminant value of th 
parameters was also inferior to that of AI. 
DISCUSSION 
To test the discriminant value of individual parameters, we lim 
corroborated the histologic diagnoses of CLH and FCCL on thr 
basis of the available biopsy specimens. Results of imnlUnopheoo-
typing (Table I) indicated a B-cellnature of the lymphoid cell infil· 
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Table Ill. Significant Intra-Group Correlations of Variables 
in Diffuse Cutaneous lymphoid Hyperplasia and Malignant 
Follicular Center Cell lymphomas (Pearson Correlation Matrix) 
L inear Correlation Between Variables Correlation 
(variables in percent) Coefficient (r)" ph 
Diffuse CLH 
1 X 10- 4 Epithelioid/giant cells-small lymphoid -0.78 
cells 
Apoptotic bodies-epithelioid/giant 0.72 7 X 10- 4 
cells 
Medium-sized lymphoid cells-large 0.70 1 X 10- 3 
lymphoid cells 
-0.58 1 X 10- 2 Eosi!\ophils- large lymphoid cells 
Mitotic figures-epithelioid/giant cells 0.53 2 X 10- 2 
Eosinophils- medium-sized lymphoid - 0.52 3 X 10- 2 
cells 
Mitotic figures-small lymphoid cells -0.51 3 X 10- 2 
Mast cells-medium-sized lymphoid -0.50 3 X 10- 2 
cells 
Mitotic figures-medium-sized lymph- 0.49 4 X 10- 2 
oid cells 
Apoptotic bodies - histiocytes/ -0.46 5 X 10- 2 
macrophages 
Diffuse cutaneous malignant FCCL 
0.72 1 X 10- 2 Mitotic figures- large lymphoid cells 
Mast cells - neutrophils 0.70 2 X 10- 2 
Apoptotic bodies-large lymphoid cells' 0.64 3 X 10- 2 
5malllymphoid cells-large lymphoid -0.64 4 X 10- 2 
cells 
Mitotic figures - neutrophils -0.62 4 X 10- 2 
--; Inverse correlations are indicated by a negative r value. Equal r values in CLH 
il\d FCCL but higher p values in the latter for a given correlation are due to unequal 
lUJl1lbers of cases. 
I Listed per groups in order of decreasing significance. 
' The semilogarithmic correlation bet\veen Al and percent large lymphoid cells 
was stronger than the linear correlation (see Fig 4b). 
trates in cases 19-29, which were considered to be malignant neo-
plastic disorders. Because B-cell monoclonahty at the DNA level 
was only demonstrated in seven of the 11 FCCl, recognition of 
malignancy of the remaining. four lesions in this group had to rely 
oil histologjc features, 111 particular on the cellular ch aractenstlcs of 
eoplastic germinal center cells [21], and on their Immunopheno-~pe. The validity of diagnoses in these four cases was, in retrospect, 
further supported by the fact that values for individual parameters 
fell well into the clusters of P0111ts represent111g FCCl With proved 
lJ1onoclonality (see Fi~s 3. and 4). The monoclonality at the Ig 
heavy-chain gene leve1 111 bIOpsy samples diagnosed as ClH (cases 6 
~nd 8, see Table I) is no novel finding. Such cases have been reported 
before; they warrant a careful follow-up because the leSIOns may 
develop into a manifest malignant lymphoma (5,22] . Our results 
document that such a "hidden" B-cellmonoclonali ty is compatible 
not only with qualitative but also quantitative histologic features of 
CI.,H. 
The quantitated cellular composition of infiltrates proved to be a 
pOwerful discriminant feature to differentiate between ClH and 
FeCL (see Table II). This finding confirms and extends some ear-
lier qualitative or semiquantitative observations [1,6,23). Con-
versely, certai n differen ces between the two groups mentioned by 
lOme authors, such as the predominance of eosinophils in CLH as 
compared to cutaneous FCCl [9], did not attain significance in our 
!tries. 
Two aspects of the correlations between variables related to the 
tellular composition of infiltrates need to be mentioned. First, if we 
disregard cases of "ClH" with B-cell monoclonality , ClH and 
FeeL are basically different processes, one reactive, the other neo-
plastic, Therefore, correlations between variables of both groups 
uken together bear little meaning, in contrast to intragroup correla-
lions. Second, because values were registered in percentages, certain 
correlations (see Table III) are trivial, e.g., the inverse corre lation 
between the relative numbers of small and of large lymphoid cells. 
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But several other significant correlations are meaningful. In ClH, 
for instance, the positive corre lation between MI and percent epithe-
lioid/ giant cells may indicate the intensity of a cell-mediated im-
mune reaction, as might the strong inverse correlation between 
percent epithelioid/giant cells and percent small lymphoid cells. 
The marked positive correlation between AI and percent epitheli-
oid/ giant cells in CLH could be related to a cytotoxic action of the 
latter. There are other exa mples, some of which are more difficult to 
interpret, e.g., correlations relating to the relative numbers of eosin-
ophi ls and mast cell s. In a previous analysis of diffuse FCCL in 
lymp h nodes [10), we have found that MI tended to loosely corre-
late with AI in a non-linear fashion. In the present study a direct 
correlation did not atta in significance, probably because of the 
smaller number of cases (11 versus 48). However, there is probably 
an indirect intra-group correlation of this type because in the 
present series of diffuse cutaneous FCCl, both MI and AI correlated 
significantly and in the positive sense with the percentage of large 
lymphoid cel ls (Table III). 
The novel and salient finding of our study is the power of AI to 
discriminate between diffuse ClH and cutaneous FCCL better than 
any other parameter tested, i.e., also better than MI. "Apoptosis" 
[24,25) designates a special, frequent type of death of individual 
cells ("programmed cell death"), different from cell necrosis and 
associated, in its classic form, with cleavage of DNA at the linker 
regions between nucleosomes, compaction of chromatin, and sec-
ondary cytoplasmic disintegration. However, more than one se-
quence of biochemical events can result in the structural aspect of an 
apoptotic body [26] . The importance of apoptosis in dermatology, 
including skin tu~ors,. has recently been reviewed [27J. Yet, to our 
knowledge, relatIOnshIps between this phenomenon and benign or 
malignant cutaneous lymphoid cell infiltrates have never been ex-
amined, nor have AI and MI of skin lymphomas and pseudolym-
phomas been compared. It is now well recognized that cell prolifera-
tion and cell death are interconnected phenomena [28]. Mitotic 
activity has long been accepted as a valuable criterion for distinguish-
ing ClH and FCCl [1,2,23]. It is also a useful prognostic indicator 
for non-Hodgkin'S lymphomas at sites other than the skin [29 ,30). 
The results of the present study document that the cell death rate, 
expressed as AI, is at least as good a criterion for discriminating 
between diffuse ClH and cutaneous FCCl as is the mitotic activity . 
It remains to be studied to what extent MI and AI in diffuse FeCl 
are inherent properties of the neoplastic cell line and what other 
factors may influence them. 
Our results relate only to the diffuse subtypes ofClH and cutane-
ous FCCL. In follicular subtypes the situation may be totally differ-
ent because MI and AI in reactive germinal centers are much higher 
than in neoplastic fo llicl es (31) . 
The definitive judgement on the practical applicabil ity and the 
predictive value of Our findings must await prospective studies in-
clud1l1g more numerous cases and a longer follow-up period. 
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